Vascular Testing Devices Market Size & Share | Industry Trends Analysis Report for 2028

Vascular Testing Devices Market Overview

Vascular disease is of two type viz. peripheral artery disease (PAD) and chronic venous insufficiency (CVI). Vascular disease can be life-threatening due to incorrect and delay diagnosis. Vascular testing devices encompass a broad range of equipment and expertise for proof of principle.

Vascular testing is also known as non-invasive vascular testing in which various technology based devices are utilized to evaluate the blood vessels. The evaluation and testing of the blood vessels can be done at the rest time or at the time of the exercise. Vascular testing is generally painless and determine the disease location and severity.

Vascular testing devices are comes with the advanced features such as digital dashboard and online interface with the remotely located facility centers. These devices also come with the specifications such as LAN/WAN and DICOM/PACS compatibility.

The increasing incidence of death and other complications due to stroke and myocardial infarction amongst those with silent asymptomatic peripheral vascular disease is the key growth factor boost the use of vascular testing devices for diagnosis purpose.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-6884

Vascular Testing Devices Market: Drivers & Restraints

The global vascular testing devices market is expected to register a significant CAGR over a forecast period. The increasing prevalence of vascular diseases and disorders, lifestyle diseases is the key factor anticipated to propel the demand for vascular testing devices and drives the growth of the global vascular testing devices market.

The technically advanced vascular testing devices allows great access to vascular disease testing in particularly non-interventional settings, which helps to diagnose more patients with disease before disease progresses to a potentially critical stage. The availability of portable and easily operable testing devices for vascular diseases is also expected to be the major factor drives the growth of the global vascular testing devices market over the forecast period.

The vascular devices also work on the telemedicine technology and send test data to a remotely located specialist for the online interpretation which anticipated to surge the demand for vascular testing devices over the long run.

However, the lack of expertise and physicians to operate vascular testing devices and to interpret the test data may restrain the growth of the global vascular testing devices market over the forecast period. The higher cost of set up of the vascular testing lab and devices may hamper the demand of vascular testing devices and restrain the growth of the global vascular testing devices market over the long run.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-6884

Vascular Testing Devices Market: Region-wise Outlook

On the basis of regional presence, the global vascular testing devices market is segmented into eight key regions: North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding China and Japan, China, Japan, and Middle East & Africa. Currently, North America is contributing the leading share to the global vascular testing devices market in terms of value and anticipated to register a significant growth over a forecast period due to developed medical infrastructure and increasing spending on high end diagnostic technologies.

Europe region also contribute significant amount of revenue share to the market followed by North America. APAC region is the most lucrative market for the vascular testing devices due to the increasing prevalence of the vascular diseases in the region and expected to show a robust growth to the global vascular testing devices market. Overall, the global vascular testing devices market is expected to show significant growth over a forecast period.

The report covers exhaustive analysis on

  • Vascular testing devices market segments
  • Vascular testing devices market dynamics
  • Historical actual market size, 2013 – 2017
  • Vascular testing devices market size & forecast 2018 to 2028
  • Vascular testing devices current trends/issues/challenges
  • Competition & companies involved
  • Vascular testing devices market drivers and restraints

Enquiry/Query @ https://www.futuremarketinsights.com/ask-question/rep-gb-6884

Vascular Testing Devices Market: Segmentation

The global vascular testing devices market is segmented on the basis of modality type, technique type, test type and end user.

On the basis of modality type, the global vascular testing devices market is segmented into:

  • Portable
  • Standalone

On the basis of technique type, the global vascular testing devices market is segmented into:

  • Arterial Doppler
  • Pulse Volume (PV) Arterial
  • Photoplethysmography
  • Color or Black And White Arterial Duplex
  • MRA
  • CT and MR Angiography
  • Standard Invasive Angiography

On the basis of test type, the global vascular testing devices market is segmented into:

  • Toe pressure
  • Transcutaneous oxygen (tcpO2 / TCOM)
  • Pulse volume recording
  • Segmental pressures
  • Skin perfusion pressure
  • Heat-controlled laser Doppler
  • Others

On the basis of end user, the global vascular testing devices market is segmented into:

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Mobile Testing Centers
  • Others

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

The Food Ultrasound Market Comprehensive Shares, Historical Trends And Forecast 2030

The food ultrasound market is expected to expand steadily over the forecast period 2020-2030. The expansion is mainly driven by growing food safety concerns over mislabeling and food adulteration by several governments.

In the recent past, regulatory authorities such as the US FDA have enacted guidelines to strengthen food safety protocols. In 2016, it updated Food Safety Modernization Act (FSMA), outlining Preventative Controls for Human and Animal Food, Produce Safety and Foreign Supplier Verification Programs.

Food ultrasound technologies have especially acquired importance in the wake of the COVID-19 pandemic. Since its onset, the FDA has encouraged greater availability of advanced imaging systems, providing significant traction to food ultrasound systems.

Request a report sample to gain comprehensive market insights @
https://www.futuremarketinsights.com/reports/sample/rep-gb-12760

“Strict government regulations to avert food adulteration and contamination, are offering growth prospects for several global and regional level manufacturer of the food ultrasound device.” concludes the FMI analyst.

COVID-19 Impact on the Market

COVID-19 inflicted economic disruptions have had a limited influence on the global sales of food. However, there was a substantial increment in demand for instant foods at the onset of the pandemic. A shift towards vegan diets is boosting the scope of testing for plant based foods. Thus, rising health awareness together with secure supply chains will bolster the growth of the food ultrasound market amid the crisis.

After emerging wiser from the 2008 financial meltdown, food processors have been highly cautious, prompting them to secure supply chains. This has enabled them to avoid acute shortages. Owing to this trend, the market for food ultrasound systems is expected to remain stable.

Food Ultrasound Market – Key Highlights

  • The global food ultrasound market is likely to exceed US$ 160 million by 2030 end.
  • The Asia Pacific will come out as a lucrative region in the global market due to growing per capita food consumption.
  • Rising inclination towards high-intensity ultrasound detection to propel market growth.
  • Meat products remain majorly tested among food types over the forecast period.

Food Ultrasound Market – Drivers

  • Growing awareness about the quality of food products among customers is promoting the target market.
  • The advancement of ultrasound detection systems for the food sector to improve food ultrasound detection is complementing market growth.

Food Ultrasound Market – Restraints

  • Technological complications and lack of skilled workforce might impact the market growth
  • Strict food safety regulations are aspects that are hindering the growth of the market.

Competitive Landscape

The global food ultrasound market is characterized by the presence of numerous global level manufacturers. Prominent strategies adopted by them include technological innovations, partnerships, collaborations with research organizations and smaller players, acquisitions and new product launches.

In 2015, Hitachi High-Technologies Corporation collaborated with QIAGEN N.V., involving initiatives to deliver important advances in molecular testing. This collaboration aimed to develop new automation based PCR and NGS systems.

In a similar vein, Siemens Healthcare has launched the ACUSON X700TM Ultrasound System, comprising a 20” LED widescreen display, 180o articulating arm, one-touch image optimization and customizable measurements & presets.

In 2017, researchers at University of British Columbia developed a laser-equipped spectrometer, complete with statistical analysis to ascertain possible adulteration of ground beef samples, with 99% accuracy.

Fujifilm manufactures the Vevo MD ultra-high frequency machine series, equipped with a Power Doppler, which is capable of visualizing the minutest anatomy which a conventional ultrasound cannot achieve.

Request for Customization @
 https://www.futuremarketinsights.com/customization-available/rep-gb-12760

Key Segments

Food Product:

  • Meat
  • Beverages
  • Fruits & Vegetables
  • Dairy
  • Bakery
  • Other Food Products

Frequency Range:

  • Low Intensity
  • High Intensity

Region:

  • North America (U.S & Canada)
  • Latin America (Brazil, Mexico, Argentina, Peru, Chile & Rest of LATAM)
  • Europe (Germany, Italy, France, U.K, Spain, BENELUX, Russia & Rest of Europe)
  • South Asia (India, Thailand, Indonesia, Malaysia, Singapore & Rest of South Asia)
  • East Asia (China, Japan & South Korea)
  • Oceania (Australia & New Zealand)
  • Middle East & Africa (GCC, South Africa, Turkey, Iran, Israel & Rest of MEA)

Download complimentary copy of Future Market Insights White Paper in collaboration with PBFIA, on the Plant Based Market that throws light on potential opportunities and investments made in the Global plant based market

About Future Market Insights (FMI)

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse Other Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

Allergy Immunotherapy Market is expected to reach a valuation of US$ 2,892.2 Mn by 2030.

According to Future Market Insights (FMI), the global Allergy Immunotherapy Market would rise steadily between 2020 and 2030. According to the analysis, the market will be worth US$ 2,892.2 million by the end of 2030.

The increasing prevalence of various kinds of allergies – allergic rhinitis, allergic asthma, food allergies, skin allergies, and others is propelling the demand for effective treatments. As patients seek advanced treatments to develop resistance against allergies and lead a hassle-free life, allergy immunotherapy has emerged as a fitting medical solution.

Moreover, allergic rhinitis is among the most common allergies, affecting 10% to 30% of the global population. Also known as hay fever, it leads to inflammation in the nose, swelling in the eyes, sneezing, among other symptoms when the person is exposed to allergens – mostly dust mites and pollen.

Request a sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-9043

Although a remarkable proportion of the population does not seek medical attention, rising awareness regarding the availability of these treatments, coupled with increased spending on healthcare is expected to remain a crucial demand-side trend through the forecast period.

Key Takeaways from the Allergy Immunotherapy Study

  • On the basis of product, injections are poised to account for over 2/3rds of market share backed by their effectiveness and easy availability
  • Based on immunotherapy, SCIT holds the lion’s share in market value, accounting for 66% of global value, while SLIT is exhibiting higher attractiveness
  • Among indications, allergic rhinitis and allergic asthma are poised to collectively account for around 3/5th of global value, ascribed to their high prevalence
  • By type of allergen, pollens and house dust mites will cumulatively account for more than 2/5th of market value since pollens such as grass pollen and weed pollen are highly common in living areas
  • Based on distribution channels, institutional sales account for more than half of overall value owing to high inpatient rates in government and semi-government hospitals
  • Europe is expected to prevail as the most lucrative regional market, on the back of the rising prevalence of different types of allergies in the region
  • North America and East Asia will cumulatively account for more than a quarter of market value, owing to the presence of a wide population base with allergies coupled with developing healthcare infrastructure

COVID-19 Impact on Allergy Immunotherapy Market

The outbreak of COVID-19 has sent ripples of uncertainty across the global pharmaceutical sector and the allergy immunotherapy market is no different. The market is expected to witness several mid-term and long-term impacts due to the pandemic, as demand for SLIT tablets and injections experiences contraction. Likewise, shifting presence towards essential drugs is causing a delay in services, thus further slowing down the growth of the market. Along similar lines, shortages of staff and hindered supply chains during nation-wide lockdowns will further challenge the growth through the pandemic.

 Request a TOC@ https://www.futuremarketinsights.com/toc/rep-gb-9043

Why Future Market Insights?

  • Comprehensive analysis on evolving purchase pattern across different geographies
    • Detailed insights of market segments and sub-segments for historical as well as forecast period
    • A competitive analysis of prominent players and emerging players in the keyword market
    • Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

Allergy Immunotherapy Market – Segmentation

Product:

  • SLIT Tablets
    • Odactra
    • Grastek
    • Ragwitek
    • Oralair
    • Actair
    • Others
  • Oral
    • Palforzia
    • Others
  • Injections
  • Others

Immunotherapy:

  • Sublingual Immunotherapy
  • Subcutaneous Immunotherapy
    • Specific Immunotherapy
  • Others

Ask An expert here @ https://www.futuremarketinsights.com/askus/rep-gb-9043

Indication:

  • Allergic Rhinitis
  • Allergic Asthma
  • Food Allergy
  • Atopic Dermatitis
  • Others

Allergen:

  • Pollens
    • Grass Pollens
    • Weed Pollens
    • Tree Pollens
  • House Dust Mites
  • Mould
  • Animal Dander
  • Bee Venom
  • Cockroaches/Insects
  • Others

Distribution Channel

  • Institutional Sales
    • Government Hospitals
    • Semi-Government Hospitals
    • Private Hospitals
  • Retail Sales
    • Retail Pharmacy
    • Drug Stores
    • Online Pharmacy

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • Oceania
  • East Asia
  • Middle East and Africa

Explore Other Reports Links From Healthcare Market:

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 8-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

Beverage Emulsion Market Size and Share Analysis by Application and segmentation Global Industry Growth Forecast to 2022-2032

The beverage emulsion market is slated to record a stagnant to moderate expansion over the assessment period 2032 as per a new study by FMI. The market sluggishness can be mainly due to the COVID-19 outbreak. The market demand is expected to sustain on account of high functional beverage uptake.

As infection cases experience a resurgence in several regions, governments are reimposing lockdowns, leading to cessation of business activities. This is bound to impact short-term outlook for beverage emulsion products and solutions.

Request a report sample to gain comprehensive market insights @
https://www.futuremarketinsights.com/reports/sample/rep-gb-12759

On the bright, however, companies are investing in innovative emulsion technological solutions, paving way for increased research and development prospects in the forthcoming forecast period.

“Growing trend of healthy drinking have prompted the customer to prefer functional and healthier beverages such as kombucha and plant-based waters, offering prospects for market players to launch specific emulsion solutions.” Concludes the FMI analyst.

COVID-19 Impact on the Market

While the COVID-19 outbreak has inflicted shot terms sluggishness in the beverage emulsions market growth, FMI in its recent study states that the rate of regaining the market growth pace in the post-pandemic landscape is anticipated to remain moderate. Market players are acknowledging the situation and fortifying their supply chains and distribution networks to counterbalance any further recessionary wave.

According to the Scientific Advisory Group for Emergencies (SAGE), the second wave of COVID-19 infections is likely to result in much higher casualties. While deaths will peak at much lower levels compared to the first wave, the number shall prevail for several months.

Beverage Emulsion Market – Key Highlights

  • Asia Pacific is anticipated to remain the fastest-growing region due to increasing probiotics uptake.
  • Xanthan gum is anticipated to register substantial growth over the forecast period.
  • Cloud emulsion techniques to lead among other emulsion type segment in the global market.
  • The non-alcoholic application segment will be gaining traction during the assessment period.

Beverage Emulsion Market – Drivers

  • Dietary preferences towards healthy drinks are propelling the market expansion.
  • Increasing investments in innovative emulsion technological solutions are enhancing growth prospects for the market.
  • Increased spending on premium clean-label emulsified beverages is fueling significant growth.

Beverage Emulsion Market – Restraints

  • Technological challenges regarding functional beverages might limit the overall growth of the market.
  • Fear of an upcoming second wave of COVID-19 infections is prompting the close down of businesses and industries, thus adversely impact the market growth.

Competitive Intelligence

Prominent vendors within the global beverage emulsion landscape rely on collaborations, acquisitions, technological innovations and new product launches to remain afloat in the market.

Some leading players in the beverage emulsion market include Dohler GmbH, Cargill Inc., Sensient Technologies Corporation, Givaudan SA, Archer-Daniels Midland Company, International Flavors & Fragrances, Kerry Group, CHr Hansen A/S, DuPont, Ingredion Incorporated, Tatel & Lyle PLC, CP Kelco and Ashland Inc.

Since 2017, Dohler GmbH has been working in conjunction with Fraunhofer Society to ensure complete food safety. With respect to the beverages sector, the company offers the Dohler Microsafety Design solution for detecting microorganisms in different beverages.

In August 2020, Cargill Foods Inc., announced a US$ 15 billion investment with respect to a new bio industrial plant, comprising of an annual capacity worth 35,000 tons in Kurkumbh, Maharashtra and will be made available to dairy farmers in and around the region.

Request for Customization@
https://www.futuremarketinsights.com/customization-available/rep-gb-12759

Key Segments

Source:

  • Xanthan Gum
  • Pectin
  • Carboxymethyl Cellulose
  • Carrageenan
  • Gellan Gum
  • Gum Arabic
  • Modified Starch

Emulsion Type:

  • Color Emulsion
  • Flavor Emulsion
  • Cloud Emulsion
  • Vitamin Emulsion

Application:

  • Non-Alcoholic
  • Carbonated Beverages
  • Dairy Beverages
  • Fruit Juices
  • RTD Tea/Coffee
  • Alcoholic Drinks

Region:

  • North America (U.S & Canada)
  • Latin America (Brazil, Mexico & Rest of Latin America)
  • Europe (Germany, Italy, France, U.K, Spain, Russia, Nordics, BENELUX, Poland & Rest of Europe)
  • South Asia (India, Thailand, Indonesia, Malaysia & Rest of South Asia)
  • East Asia (China, Japan & South Korea)
  • Oceania (Australia & New Zealand)
  • Middle East & Africa (GCC, South Africa & Rest of MEA)

Download complimentary copy of Future Market Insights White Paper in collaboration with PBFIA, on the Plant Based Market that throws light on potential opportunities and investments made in the Global plant based market

About Future Market Insights (FMI)

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse Other Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

The Food Acidulants Market by 2022-2032: Share, Size, Forecast and Trends

The food acidulants market is projected to grow from USD 3.1 billion in 2022 to USD 6.5 billion by 2032, at a Compound Annual Growth Rate (CAGR) of 5.1% during the forecast period.

As urbanization expands, demand for ready-to-eat foodstuffs is increasing, attributed to the adoption of hectic lifestyles. Consequently, their supply is increasing rapidly, filling up shelves in supermarkets and departmental stores. This is providing major traction to food acidulants as they help enhance the shelf-life of such products.

Increasing awareness about food acidulants helping regulate pH levels, olfactory properties preservation, acidity levels regulation and overall enhancement of the functional characteristics of food & beverages are increasing their uptake across numerous food products.

Acidulants and citrates are common ingredients in food and beverages because of the specific capabilities they provide. The role of food Acidulants in the food industry is extremely diverse, ranging from pH correction and flavour improvement to the prevention of enzymatic browning in fresh foods.

Get | Download Sample Copy with Graphs & List of Figures: https://www.futuremarketinsights.com/reports/sample/rep-gb-12665

Key Takeaways

Liquid form food acidulants to find growing adoption, owing to high beverage consumption Citric acid to emerge as the most widely used food acidulants, attributed to its flavor enhancing properties Food acidulants as preservatives are poised to find immense application across ready-to-eat foodstuffs Beverages segment to register extensive usage of food acidulants through 2030 Asia-Pacific to be the fastest growing region, North America likely to retain market dominance

COVID-19 Impact Insights

With the world hurtling towards a major financial meltdown, the market for food acidulants is expected to take a substantial hit in its revenue and growth projections until the latter-half of 2021. The pandemic has compelled governments to impose shutdowns, thus impacting industrial production and profit margins across prominent sectors.

Logistical difficulties in procuring raw materials to manufacture food acidulants is leading to production crunches, generating a demand-supply gap. However, this is likely to be offset due to a sustained demand for instant foods and beverages from consumers.

Since the past two months, lockdown restrictions are being lifted, permitting movement of goods and material from one place to another. Also, production cycles are gradually being restored, causing revenue pools to expand. This is likely to sustain projections for the food acidulants market in the coming future.

Food Acidulant Market Players

The global food acidulants market is highly fragmented, characterized by the presence of several regional and international players. Some prominent players profiled in the report are Tate & Lyle plc, Archer Daniels Midland Company, Brenntag AG, Cargill Inc., FBC Industries Inc., Hawkins Watts Ltd. and Isegan South Africa (Pty) Ltd.

Food Acidulants Market Segmentation

Form Type

Solid Liquid

Type                

Citric Acid Lactic Acid Phosphoric Acid Other Types

Function

Preservative Acidity Regulator Antimicrobial Flavor Enhancer Other Functions

Application

Bakery and Confectionery Beverages Meat Poultry and Sea Foods Sauces and Dressings Other Applications

Discover more about report analysis with figures and data tables, along with the table of contents. Ask an Analyst- https://www.futuremarketinsights.com/ask-question/rep-gb-12665

Key Questions Answered in the Report

How much is the Food Acidulants market current worth?

Currently Food Acidulants market is worth more than US$ 3.1 Bn.

At what CAGR is the market expected to grow?

Food Acidulants consumption is expected to grow at a CAGR of around 5.5 % during the period 2021-2031.

How was the performance in the last five years?

In terms of revenue, Food Acidulants grew at a CAGR of around 6.2% during 2016-2020

What are the key trends boosting Food Acidulants sales?

Nutritional and allergen-free characteristics of Food Acidulants, increasing demand for Food Acidulants in food and beverages markets. The supply chain disruptions have increased the usage of food acidulants.

How are market players reacting to the new developments in the market?

Market players are opting for technological advancement, new product developments, and production to increase stability at certain temperatures.

Download complimentary copy of FMI’s market report on ‘Plant Based Revolution’: Growth opportunities and winning strategies in the Plant Based Food Market

About FMI

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com

Browse Other Reports: https://www.futuremarketinsights.com/reports

LinkedIn| Twitter| Blogs

Upper Limb Prosthetics Market is estimated to expand at a CAGR of 4.9% through 2028.

In 2022, global sales of upper limb prosthetics are expected to be over US$ 379 million. According to thorough industry research, the global Upper Limb Prosthetics Market is expected to grow at a CAGR of 4.9% and reach a valuation of US$ 505 Mn by 2028.

Upper limb prostheses have been progressing at a slow but steady rate in the recent past. Aside from an increasing trend in cosmetic prostheses, the incidence of sports injuries is considerably contributing to the global market need for upper limb prosthetics.

Use of additive manufacturing/3D printing for prosthetics has been gaining momentum within the marketplace, particularly among amputees who are unable to afford the high price point associated with conventional limb prosthetics. Adoption of upper limb prosthetics has been pervasive at hospitals, at a steadily increasing rate.

FMI expects a higher rate of adoption across prosthetic clinics in the years to come. However, an expensive price point, coupled with mass production incompatibility, is most likely to limit rapid revenue growth of upper limb prosthetics market.

Download Sample Copy @ https://www.futuremarketinsights.com/reports/sample/rep-gb-8991

Several prominent players in the competitive landscape of upper limb prosthetics market are prioritizing new product launches eyeing the opportunities lying in competitive price ranges. While this strategy is likely to aid companies improve penetration into developing markets, others will also focus on development of convenient accessories to assist the usage of upper limb prosthetics – such as hand gloves.

As per FMI’s analysis, a considerable number of companies competing in upper limb prosthetics market are concentrating on providing rehabilitative prosthetic services and amputee care. Consistently increasing demand for prostheses following accidental and aging related disabilities will primarily push sales of upper limb prosthetics. Rapid surge in the number of orthopedic disorders and post-traumatic disabilities will also remain a key factor determining demand for upper limb prosthetics in the near future, according to the report.

Prosthetic Wrist to Hold over One-Fourth Market Share

Transradial disarticulation (below elbow) will remain the key indication generating maximum demand for upper limb prosthetics. The report points to a higher revenue share of over 1/4th of the total value, collectively contributed by wrist disarticulation and transhumeral disarticulation (above elbow). Sale of partial hand has also been registering a moderately growing share in the market revenue.

Prosthetic wrist sales account for over a fourth of the total market value whereas, prosthetic arm is likely to develop highest-selling potential in the years to come. Prosthetic elbow and terminal devices are currently among highly sought after components of upper limb prosthetics after prosthetic wrist, according to FMI’s study. The combined revenue share of these two in the market has been anticipated to be more than 45% in 2019. However, prosthetic shoulders will also continue to experience moderate demand over the course of next few years.

Almost 2/5th of the total demand for upper limb prosthetics is accounted by myoelectric prosthetic devices, followed by body powered counterparts. As per FMI’s analysis, passive prosthetic devices can be positioned as a relatively lucrative type of upper limb prosthetics.

North America & Europe Hold over 55% Share in Market Value

While more than 55% share of the global market revenue is contributed by developed regional markets, the penetration of upper limb prosthetics within most of the developing regions remains in its latency. According to FMI’s study, the market in China, India, and some of the fast-developing economies in East and South Asia economies hints at promising growth prospects post 2019. The report attributes this growth to the sophistication of healthcare infrastructure, improvements in reimbursement scenario, rapid expansion of the patient pool, and the flourishing medical tourism sector.

Increasing per capita healthcare spending, spike in the private and public investments in R&D, and the influx of activities involving shifting of manufacturing bases to developing regional pockets have also been instrumental in establishing a positive growth outlook for upper limb prosthetics market in these regions.

FMI forecasts a 4.9% CAGR for the upper limb prosthetics market revenue over 2022-2028. The report has tracked some of the most prominent players active in the global upper limb prosthetics market, including Fillauer LLC, Touch Bionics Inc., Endolite India Ltd., College Park Industries, and Ottobock SE & Co. KGaA, among others.

Get In Touch With Our Team For 20% Flat Discount @ https://www.futuremarketinsights.com/ask-question/rep-gb-8991

Key Segments of Upper Limb Prosthetics Industry Survey

Upper Limb Prosthetics Market by Product:

  • Passive Prosthetic Devices
  • Body-powered Prosthetic Devices
  • Myoelectric Prosthetic Devices
  • Hybrid Prosthetic Devices

Upper Limb Prosthetics Market by Component:

  • Prosthetic Wrists
  • Prosthetic Elbows
  • Prosthetic Shoulders
  • Prosthetic Arms
  • Terminal Devices

Upper Limb Prosthetics Market by Indication:

  • Forequarter Amputations
  • Shoulder Disarticulations
  • Transhumeral Disarticulations
  • Elbow Disarticulations
  • Transradial Disarticulations
  • Wrist Disarticulations
  • Partial Hand Amputations
  • Fingers Amputations

Upper Limb Prosthetics Market by End User:

  • Hospitals
  • Prosthetic Clinics
  • Rehabilitation Centers

Upper Limb Prosthetics Market by Region:

  • North America Upper Limb Prosthetics Market
  • Latin America Upper Limb Prosthetics Market
  • Europe Upper Limb Prosthetics Market
  • East Asia Upper Limb Prosthetics Market
  • South Asia & Pacific Upper Limb Prosthetics Market
  • Middle East & Africa (MEA) Upper Limb Prosthetics Market

Explore FMI’s Extensive ongoing Coverage on Healthcare Domain:

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 6-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

Pea Starch Concentrate Market Size, Share, Industry Analysis, Future Growth, Segmentation, Trends and Forecast 2022-2032

The global market of pea starch concentrate is poised for a promising uptick in revenues. The growth of the market can be largely attributed to superior performance in food processing applications, as an extrusion ingredient for moisture control in products ranging from processed meat to bakery and confectionery products.

According to a recent report by Future Market Insights (FMI), the market is projected to witness steady growth between 2022 and 2032. On the other hand, uncertainty over the severity and the duration of the ongoing coronavirus pandemic is an area of concern in terms of supply chains and reducing demand for processed foods in the food service sector.

The market is expected to display stronger growth in the years to come, especially with rise in niche applications in animal feed, pet food and pharmaceutical production. Efforts to improve nutrition profiles in these sectors has supported growth in the industry.

Click the link to get a free Sample Copy of the Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-12546

Pea starch concentrate finds role in clean label practices in personal care, pharmaceuticals, cosmetics, and food formulations. Nutrition benefits in controlling cholesterol levels, blood pressure, obesity, and antioxidant properties will be key factors driving adoption for the foreseeable future.

FMI’s report on the market offers a detailed overview, covering key market dynamics. Some of the takeaways from the report are as follows:

  • The value of the market for pea starch concentrate is estimated at US$ 811 Mn in 2020, which is a decrease than the previous year
  • Sluggish growth is expected in the current year (2020) as a result of supply chain concerns, and reduced demand from food industry end users during the ongoing pandemic
  • Conventional pea starch concentrate is projected to account for major revenue share, owing to higher global agriculture yields and cost benefits to end user sectors
  • North America is a prominent market. However, Asia Pacific is likely to provide lucrative opportunities, with a relatively higher growth rate through 2030, owing to a vast population and growing consumer awareness about health and wellness association to diets

“The higher amylose content of pea starch concentrate enables higher levels of stability under more extreme environment conditions in comparison to other products. These characteristics of heat and acidic resistance will bolster demand in food applications and will support overall market growth during the projection timeframe,” said a lead analyst at FMI.

COVID-19 Impact on Pea Starch Concentrate Market

Pea starch concentrate manufacturers are expected to face the adverse effects of the coronavirus crisis. The pandemic is expected to generate sluggish growth prospects for the industry in the short term, owing to the non-essential nature of its applications in multiple sectors including cosmetics, and processed snacks.

On the other hand, potential applications of pea starch concentrate in pharmaceutical products, coupled with consumer bias towards convenience foods during the outbreak has generated key growth opportunities for players in the industry. Recovery is likely to be gradual towards the end of 2020 as the severity and the duration of the pandemic continues to result in operational and economic uncertainties.

Who is winning?

FMI in its report analyses the strategies being employed by key companies running the pea starch concentrate market. Most producers are focused on the product improvements in addition to emphasizing on strategic acquisitions for geographic and capacity expansions in the long term.

Some of the companies operating in the pea starch concentrate market are Ingredion Inc, Roquette Freres, The Scoular Company, Cosucra Groupe Warcoing S.A., AGT Food and Ingredients, and Meelunie BV among others.

Key Segments

Product Type

  • Yellow Peas
  • Green Peas

Nature

  • Organic
  • Conventional

End Use

  • Sups & Sauces
  • Confectionery
  • Bakery
  • Breakfast Cereals
  • Ice-Cream & Desserts
  • Pasta & Noodles
  • Snacks & Savory
  • Processed Meat Products
  • Animal Feed
  • Pet Food
  • Pharmaceuticals

Grade

  • Food Grade
  • B2C/Indirect
  • Industrial Grade

Regional Outlook

  • North America (U.S., Canada)
  • Latin America (Mexico, Brazil, Rest of LATAM)
  • Europe (EU-4, U.K., Benelux, Nordics, Russia, Poland, Rest of Europe)
  • East Asia (China, Japan, South Korea)
  • South Asia (India, Thailand, Malaysia, Indonesia, Singapore, Rest of South Asia)
  • Oceania (Australia, New Zealand)
  • Middle East & Africa (GCC Countries, Israel, South Africa, Turkey, Iran, Rest of MEA)

Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-12546

Frequently Asked Questions

  • What is the pea starch concentrate market size?
  • Which are the top companies in pea starch concentrate market?
  • What are the applications of pea starch concentrate?
  • From what sources are pea starch concentrates derived from?
  • What are the challenges faced in pea starch concentrate market?
  • Will South Asia exhibit high demand for pea starch concentrates?

Download complimentary copy of FMI’s market report on ‘Plant Based Revolution’: Growth opportunities and winning strategies in the Plant Based Food Market

About FMI

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com

Browse Other Reports: https://www.futuremarketinsights.com/reports

LinkedIn| Twitter| Blogs

Dextrose Monohydrate Market is projected to grow at a CAGR of 15.6% by 2022 to 2032: Future Market Insights, Inc.

The global dextrose monohydrate market size is expected to reach US$ 5.0 Bn by the end of 2032. According to the recent study by Future Market Insights (FMI), the market will surge at 2.1% CAGR between 2022 and 2032. According to the report, growing demand for packaged and convenience food products and high disposable income are expected to drive the dextrose monohydrate market. This report gives a descriptive study of the market along with the growth drivers, opportunities, restraints in the growth and key market trends.

Dextrose monohydrate is used in powder and tablet form and in isotonic and hypertonic solutions for medical purposes. It is combined with vitamin D and minerals such as calcium are used for the preparation of glucose tablets. It is also used to treat diabetic patients’ hypoglycaemia. In combination with ascorbic acid it can be used to treat various disorders, heart problems and concerns pertaining to intoxications.

Dextrose monohydrate finds increasing use in confectioneries. It is commonly used in the manufacturing of diverse confectionery items such as chewing gums and chocolates. It also has great preservative properties, which increases the end product’s shelf life. This has contributed to increased use of dextrose monohydrate in confectionaries.

To Get Sample Copy of Report visit @ https://www.futuremarketinsights.com/reports/sample/rep-gb-11607

It includes in-depth insights into the dextrose monohydrate market. Some of these are:

  • The estimated value of the market was at US$ 4.1 Bn in 2020.
  • North America dextrose monohydrate market is expected to account for highest revenue share.
  • On the basis of form, food grade accounts the highest share.
  • Among the application segment, the bakery & confectionery segment is projected to hold highest share in terms of revenue.
  • Dextrose monohydrate has high nutritional value and is commonly used as a sweetener in the food and beverage industry as well as in the pharmaceutical industry.

“The rising demand for dextrose monohydrate in food sector will propel growth. In addition to this, the rising use in pharmaceuticals for the development of antacid suspensions, rising purchasing ability of consumers and shifting individual lifestyles are some factors that are expected to drive the in the years to come. Market players are likely to take cue from changing consumer preferences to develop products and gain competitive advantage,” said a lead analyst at FMI.

Who is Winning?

The global dextrose monohydrate market is highly competitive market. The presence of major players operating are Tereos, Global Sweeteners, Cargill, Roquette, Ingredion, Tate & Lyle, ADM, Xiwang Group,  Lihua Starch, Zhucheng Xingmao Corn Developing among others. The report will offer a comprehensive outlook into the competitive landscape of the market. Strategies adopted by the market players are assessed in details. Furthermore, the report offers insights into investment feasibility across various segments and provides recommendations to help the market players gain competitive advantage.

Get Valuable Insights into Dextrose Monohydrate Market

Future Market Insights, in its new report, presents an unbiased analysis of the global dextrose monohydrate market, covering historical demand data and forecast figures for the period between 2020 and 2030. The study divulges compelling insights into growth witnessed in the market. On the basis of product type, market is segmented into food grade, medical grade and others. On the basis of application, market is segmented into beverages, dairy foods, bakery & confectionery, convenience food, pharmaceuticals and others. Regionally, the market can be segmented into North America, Latin America, Europe, East Asia, South Asia, Oceania and MEA.

Ask More about This Report@ https://www.futuremarketinsights.com/ask-question/rep-gb-11607

DEXTROSE MONOHYDRATE MARKET – KEY RESEARCH FINDINGS

  • The dextrose monohydrate market will expand at a CAGR of 2% between 2020 and 2030
  • The food industry utilizes dextrose monohydrate as a preservative to increase the shelf life of packaged foods
  • North America would remain at the driver’s seat in the dextrose monohydrate market
  • Europe and Asia Pacific to remain attractive markets for dextrose monohydrate
  • The market is witnessing a demand upswing in bakery & confectionery segment
  • In addition, the rapidly expanding beverages industries, soaring overall economic mechanisms and need for quality food products are expected to drive growth

About FMI

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com

Browse Other Reports: https://www.futuremarketinsights.com/reports

LinkedIn| Twitter| Blogs

Aemia Treatment Market Size to Reach US$ 14.9 Bn by 2028 | CAGR of 6.9% – Future Market Insights

According to a Future Market Insights (FMI) analysis, the Anaemia Treatment Market would exceed US$ 10.0 billion by 2022. More than 70% of anaemia treatment is sought for normocytic anaemia, with microcytic anaemia coming in second.

According to a new research analysis by Future Market Insights, the condition as a result of one or more chronic diseases drives the majority of the demand for anaemia therapy.

One of the non-communicable chronic conditions responsible for the epidemiological transition of developing regions, chronic kidney disease (CKD) is a key factor fuelling demand for anemia treatment. Anemia treatment market is also receiving a strong impetus from the rising popularity of combination therapy. Increasing use of vitamin and iron supplements, antibiotics, metal chelating agents, and erythropoietin stimulating agents in combination therapy is cited as in important factor pushing prospects of anemia treatment market in upcoming years.

Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-8966

Vitamin Supplements Gains Significant Traction for Anemia Treatment

A surge in R&D investments is prominently improving scope of anemia treatment. Moreover, a rising number of pipeline drugs and promising potential of biosimilars will contribute to the demand for anemia treatment. However, high price point associated with biologics continues to mask their superior treatment efficacy over conventional medications.

More than 75% of anemia treatment market revenue is accounted by medications, of which, ESAs (erythropoietin stimulating agents) remain bestselling. Blood transfusion also cited as an important type of anemia treatment, contributing to the market growth. However, the demand for former is poised for a robust double-digit yearly growth in 2021 and ahead.

Lucrative emergence of ESAs and soaring consumption of other biosimilar medications are likely to introduce new investment opportunities in anemia treatment market. Extensive availability, accessibility, and economic price point of biosimilar drugs is strongly backed by an increasing number of FDA approvals. This according to FMI will significantly contribute in improvement of CKD, thereby bolstering the revenue of anemia treatment market. FDA recently issued an approval to a biosimilar drug by Pfizer for use in anemia treatment – Retacrit (epoetin alfa-epbx).

Over 55% of dietary supplements consumed as a part of anemia treatment are vitamin supplements. An increasing number of iron deficient patients will reportedly result in rapid demand growth of iron supplements in years to come, posing strong competition to that of vitamin supplements in the anemia treatment market. Currently, almost 60% of the medications and dietary supplements for anemia treatment is available at institutional pharmacies. The report also points to a gradually expanding share of retail pharmacies in the near future.

Just-under a third of the global demand for anemia treatment is raised by North American patients, whereas more than a third of the total demand is accounted collectively by East and South Asia. Europe is also cited as one of the key regional markets for anemia treatment providers.

Contact our Market Research Specialist @ https://www.futuremarketinsights.com/ask-question/rep-gb-8966

Product-based Business Models Emerge as a Key Competitive Strategy

The consistent quest for therapeutically effective ESAs, dietary supplements, antibiotics, and other biologics to be used in anemia treatment continues to create attractive avenues in the R&D realm. Leading drug manufacturers are investing efforts in launching novel products and upgrading their existing consumable product portfolios. Amgen’s epoetin alpha has been a breakthrough product since its launch in the CKD treatment landscape and growing adoption continues to benefit the company.

Besides augmenting R&D investments, prominent players in anemia treatment market are also focusing on strategic agreements and partnerships – further paving the way for development of anemia treatment drugs. Emergence of partnership-based models in the competitive landscape of anemia treatment market is likely to reshape R&D structure in the anemia treatment market. The report prompts at major investment opportunities arising in open collaboration strategies. A number of drug manufacturers are also opting for partnerships with regional distribution leaders to form effective product-based distribution channels, particularly targeting developing regional markets.

Request Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-8966

Anemia Treatment Market by Category

By Treatment:

  • Medications
  • Dietary Supplements

By Disease:

  • Normocytic anemia
  • Microcytic anemia
  • Macrocytic anemia

By Distribution Channel:

  • Institutional Pharmacies
  • Retail Pharmacies
  • Mail Order Pharmacies

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Explore Wide-ranging Coverage of FMI’s Healthcare Landscape:

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

Cytomegalovirus Treatment Market is predicted to increase at a CAGR of 6.1% from 2022 to 2028.

The Cytomegalovirus Treatment Market is expected to rise to US$ 228.8 million by 2022. Demand for cytomegalovirus therapy is expected to reach a market worth of US$ 326 Mn by the end of 2028,

The number of people with CMV is steadily increasing, prompting the introduction of efficient treatment plans and medicines. According to information provided by MedlinePlus, by the time they are 40, between 50 and 80 percent of persons in the US have had CMV symptoms.

According to these statistics, the use of CMV treatment products and techniques will increase in the future, providing producers with ongoing potential to generate sizable profits.

Download Sample Copy @ https://www.futuremarketinsights.com/reports/sample/rep-gb-8665

Hospital Pharmacies Remain Highly Lucrative Channel for Manufacturers with Notable ROI Benefits

As per the report, congenital CMV infection registers substantial demand for cytomegalovirus treatment, with global sales expected to surpass over US$ 65.5 Mn in 2019. Hospital pharmacies are likely to steer sales of cytomegalovirus treatment products and procedures, owing to reliable offerings at reasonable costs.

E-commerce is a fast expanding distribution avenue for manufacturers to market their products because well-informed, contemporary patients want a combination of efficiency and ease.

According to the analysis, the high cost of CMV treatment techniques continues to be a major barrier to adoption and to the market’s potential for growth. The accompanying negative effects of CMV treatment products and procedures are eroding end-user confidence in addition to their expensive prices.

Neutropenia, nausea, thrombocytopenia, haematological toxicity, renal failure, and others are some of the often occurring side effects connected with CMV therapy products and techniques.

Manufacturers in the market for CMV therapy are concentrating on cutting-edge research, leading to improved products with improved features. The market participants are also emphasising the availability of products in various size dimensions to promote consumer convenience.

A number of strategic alliances, purchases, and mergers are taking place in the cytomegalovirus treatment business, allowing the manufacturing firms to combine their production know-how to create competitive products. To broaden its exclusive line of science-based dermocosmetic beauty products, Johnson & Johnson, for instance, completed the acquisition of Ci:z Holdings Co., Ltd. in 2019.

Key Segments of Cytomegalovirus Treatment Industry Survey

Cytomegalovirus Treatment Market by Drug Type:

  • Valganciclovir for Cytomegalovirus Treatment
  • Ganciclovir for Cytomegalovirus Treatment
  • Cidofovir for Cytomegalovirus Treatment
  • Foscarnet for Cytomegalovirus Treatment
  • Others

Cytomegalovirus Treatment Market by Application:

  • Stem Cell Transplantations
  • Organ Transplantations
  • Congenital CMV Infections
  • Others

Cytomegalovirus Treatment Market by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • e-Commerce

Get In Touch With Our Team For 20% Flat Discount @ https://www.futuremarketinsights.com/ask-question/rep-gb-8665

Cytomegalovirus Treatment Market by Region:

  • North America Cytomegalovirus Treatment Market
  • Latin America Cytomegalovirus Treatment Market
  • Europe Cytomegalovirus Treatment Market
  • East Asia Cytomegalovirus Treatment Market
  • South Asia & Pacific Cytomegalovirus Treatment Market
  • Middle East & Africa (MEA) Cytomegalovirus Treatment Market

More Trending Reports by Future Market Research: 

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs